#Greed CEO says drug price will be lowered after hike from $13.50 to $750 a tablet

 

The former hedge fund manager who ignited a firestorm of criticism over drug prices after hiking the price of a specialized drug from $13.50 a tablet to $750 a tablet said in an interview Tuesday his company will substantially lower the price.

Martin Shkreli, CEO of Turing Pharmaceuticals, told ABC News his company will lower the price of Daraprim after several days of making headlines and receiving complaints from medical groups, however he did not specify the new cost.

Source: CEO says drug price will be lowered after hike from $13.50 to $750 a tablet | Fox News

Advertisements